Biotech Values

[DFRAI]

dewophile et al

Why would Sandoz have to give notice to TEVA of launching copaxone if FDA approves??????? at all???

I presume the judge is familiar with FDA action date - spring 2011, and there is some pressure to wrap up the suit before than - if not, Sandoz could launch at risk and force the courts to expedite the patent dispute together with any injuction suit filed by TEVA.